These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29796029)

  • 1. The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction.
    Aslanabadi N; Safaie N; Talebi F; Dousti S; Entezari-Maleki T
    Iran J Pharm Res; 2018; 17(Suppl):53-63. PubMed ID: 29796029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population.
    Aslanabadi N; Safaie N; Shadfar F; Taban-Sadeghi MR; Feizpour H; Mashayekhi SO; Hamishehkar H; Aghdam NK; Dousti S; Namdar H; Entezari-Maleki T
    J Res Pharm Pract; 2015; 4(4):206-11. PubMed ID: 26645027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
    Betancourt BY; Marrero-Miragaya MA; Jiménez-López G; Valenzuela-Silva C; García-Iglesias E; Hernández-Bernal F; Debesa-García F; González-López T; Alvarez-Falcón L; López-Saura PA;
    BMC Clin Pharmacol; 2005 Nov; 5():5. PubMed ID: 16262910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.
    Khalili H; Talasaz AH; Jenab Y; Salarifar M
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):708-15. PubMed ID: 22914305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction].
    Tomasević M; Kostić T; Apostolović S; Perisić Z; Djordjević-Radojković D; Koraćević G; Salinger-Martinović S
    Srp Arh Celok Lek; 2008; 136(9-10):481-7. PubMed ID: 19069338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study.
    Angamo MT; Chalmers L; Curtain CM; Yilma D; Bereznicki L
    J Clin Pharm Ther; 2018 Dec; 43(6):790-798. PubMed ID: 29722039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction].
    Kostić T; Perisić Z; Milić D; Apostolović S; Martinović SS; Bozinović N; Mitov V; Vidanović M
    Vojnosanit Pregl; 2009 Mar; 66(3):218-22. PubMed ID: 19341228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients.
    Kiguba R; Karamagi C; Bird SM
    BMJ Open; 2017 Jan; 7(1):e010568. PubMed ID: 28110281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Van de Werf F
    J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of ST-segment elevation after streptokinase therapy in anterior versus inferior wall myocardial infarction.
    Guzman E; Khan IA; Rahmatullah SI; Verghese C; Yi KS; Niarchos AP; Ansari AW; Cohen RA
    Clin Cardiol; 2000 Jul; 23(7):490-4. PubMed ID: 10894436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction.
    Schröder K; Wegscheider K; Neuhaus KL; Tebbe U; Schröder R
    Heart; 1997 Jun; 77(6):506-11. PubMed ID: 9227292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients.
    Masoomi M; Samadi S; Sheikhvatan M
    Cardiol J; 2012; 19(2):168-73. PubMed ID: 22461050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.